together by hydrogen bonds. Glutamine repeats may function as polar zippers, for example, by joining specific transcription factors bound to separate DNA segments. Their extension may cause disease either by increased, nonspecific affinity between such factors or by gradual precipitation of the affected proteins in neurons.
Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamines near the N termini of the affected proteins (for reviews, see refs. 1 and 2). They are Huntington disease (HD); spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease; spinocerebellar ataxia type 1 (SCA1); and dentatorubralpallidoluysian atrophy (DRPLA) (3) (4) (5) (6) (7) (8) . All four diseases become more severe and begin earlier the longer the glutamine repeats. The repeats tend to lengthen in successive generations of affected individuals, especially in male transmission. So far no molecular function has been proposed for the glutamine repeats. We suggest that they act as polar zippers, joining protein molecules together similarly to the way leucine zippers join the transcription factors c-Jun and c-Fos.
The gene for the HD protein contains an open reading frame for >3100 amino acid residues. Its amino acid sequence shows no homology with any known protein. The glutamine-rich segment starts at residue 18 . In healthy individuals its length varies between 16 and 33 residues; in those afflicted by HD it may vary between 35 and >100 residues. It is followed by an almost continuous stretch of 29 prolines. Poly(L-proline) forms a rigid helix with threefold screw symmetry and an axial repeat of 3.1 A per residue (9) . Its position near the N terminus of the HD protein implies that the glutamine repeat is mounted at the end of either a 90-A-long stalk or, if an intervening peptide with the sequence QAQPLLPQPQ divides it into two, at the end of two consecutive, >3A-long stalks: a bizarre structure of a kind not encountered before.
SBMA is linked to the expansion of a glutamine-rich segment in the androgen receptor. This is a transcription factor made of a 920-residue chain with one DNA-binding C-terminal domain. Starting at residue 58, healthy individuals' receptors have a sequence of 15-31 glutamines. In SBMA patients this is expanded to 40-62 (4, 5) . An androgen receptor with an expanded glutamine repeat trans-activated an androgen-responsive reporter gene more weakly than a normal receptor (10) . No complete amino acid sequence of the protein responsible for SCA1 has been published. The length of its glutamine repeat varies from 25 to 36 residues in normal individuals from 43 to 81 residues in SCA1 patients (6) .
Structure of Poly(L-glutamine). What could be the structure ofpoly(L-glutamine)? Perutz et al. (11) found several proteins containing repetitive sequences of polar residues. Molecular modeling showed these to be capable of linking (-strands together into sheets or barrels by networks of hydrogen bonds between their main-chain amides and between their polar side chains. Perutz et al. called these sequences polar zippers. One such sequence was a continuous stretch of up to 65 glutamines in the female sterile homeotic protein of Drosophila (12) . Fig. 1 shows a computer-generated, stereochemically satisfactory model of two pairs of antiparallel ,3strands of poly(L-glutamine) linked together by hydrogen bonds between their main-chain and side-chain amides.
When the importance of glutamine repeats in human disease became apparent, we decided to test the validity of this model experimentally, but this was difficult because poly(Lglutamine) is insoluble in water. To make it soluble, we synthesized a peptide with the sequence Asp2-Glnl5-Lys2.* Filtration of the peptide through Beckman Ultraspherogel SEC 2000 showed two fractions, one corresponding to the molecular weight of a monomer and the other to a broad distribution of aggregates of molecular weights in the range of hundreds of thousands. We investigated the conformation of the peptide by ultraviolet circular dichroism (CD). To avoid interactions between COO-and NH' groups, we measured the CD spectra in solutions at pH 3.0 and 2.0, where the carboxylates are protonated. Peptides forming a-helices, 3-sheets, or random coils give the different CD spectra shown in Fig. 2a . Fig. 2b shows the CD spectra of our peptide in three different solvents to be of the 13-sheet type, even though one of the solvents, trifluoroethanol, normally induces formation of a-helices. Molar residue ellipticity at 197 nm was independent of peptide concentration, suggesting that the monomers form hydrogen-bonded hairpins and that the aggregates are made of tightly linked (-sheets. The spectra were qualitatively the same at pH 7.0 and 3.0. At pH 7.0 the peptide gradually precipitated. When viewed under Abbreviations: HD, Huntington disease; SBMA, spinal and bulbar muscular atrophy; SCA1, spinocerebellar ataxia type 1; DRPLA, dentatorubral-pallidoluysian atrophy. *The peptide was prepared by continuous-flow solid-phase synthesis by fluorenylmethoxycarbonyl chemistry on an automated synthesizer (NovaSyn Crystal) employing standard protocols (13, 14) . On completion of the synthesis, the free N terminus was acetylated with acetic anhydride (20 equivalents) for 30 min. The peptide was cleaved from the Rink amide linker with trifluoroacetic acid/ phenol/triethylsilane (23 ml/1 g/l ml for 500 mg of peptide-resin assembly) and purified to homogeneity by preparative HPLC (Vydac C8 column) (13, 14 (24) .
